NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I agree Beartrap, I've always believed that CRL has the potential of providing the vaccine in much of the world, and the remainder handled in Sawston. The question in my mind is, does CRL pay NWBO for the rights to produce the vaccine and use the EDEN units, or is it the other way around with NWBO paying them to do it. The difference between on scenario and the other would be how much each receives for every batch of the vaccine that's made and distributed over time. There are virtually unlimited ways the agreement could be structured.

It's my belief that if this is done with CRL, it will be them, not NWBO, who'll be taking almost total responsibility for manufacturing, storage, distribution and sales in much of the world. CRL is already a large company, but some growth may be needed. NWBO on the other hand may minimize growth mainly to develop new trials and products. If NWBO chooses to continue to contract out much of their work, the growth of the company could be quite small, but FlaskWorks itself might grow dramatically depending on the demand for the EDEN unit, and perhaps other similar devices for producing other personalized products.

Gary